michael-muehlegger

Michael Mühlegger

Senior Director Marketing & Inside Sales

Michael Mühlegger is the Head of Marketing and Inside Sales at Single Use Support. He has 10+ years experience in the fields of marketing, inside sales, communications, content management, and creative production. With a keen understanding of market dynamics and customer behavior, Michael has successfully implemented innovative marketing strategies to drive business growth and enhance brand visibility.

He has a strong background in content management, with a focus on life sciences and biopharma trends, and is adept at creating compelling content across multiple platforms to engage audiences and effectively communicate brand messages.

 

Articles written by Michael Mühlegger

News

Innovations for the biopharmaceutical industry made in Tyrol

michael-muehlegger

Michael Mühlegger

June 14, 2022

Cell & Gene Therapy

Gene therapy manufacturing - 5 requirements to scale up

Gene therapies have become a highly promising field of groundbreaking next generation treatment, but there are some challenges to face within the manufacturing process. Here are 5 factors that will be crucial for upscaling gene therapy manufacturing with single-use technology.

michael-muehlegger

Michael Mühlegger

June 9, 2022

Biopharma

Industry 4.0 in Biomanufacturing: RoSS.KSET as an example

Industry 4.0 has long become reality in many branches. In Pharma 4.0 intelligent industrial applications and IoT enable players in the bioeconomy industry  to transition to operations that help them improve their productivity. Pharma 4.0 also has become a major part in single-use technologies, as it brings companies to the next level concerning the scalability, productivity and efficiency of their processes and products. 

michael-muehlegger

Michael Mühlegger

May 18, 2022

Single-use Technology

Small volumes of ATMPs: Safe handling of single-use bags

Cell and Gene therapies such as CAR T-cell therapy have proven their potential to become standard treatments to hard-to-treat diseases. Single Use Support has developed solutions for crucial challenges - read more!

michael-muehlegger

Michael Mühlegger

December 2, 2021

Cell & Gene Therapy

Small batch manufacturing & fill-finish in cell and gene therapy

A great example is the treatment of insidious cancers with CAR T-cells, that relies on modifying the patient’s own T-cells to instill them with a targeted way to fight cancer cells. Learn more why forming strong collaborations will solve many issues!

michael-muehlegger

Michael Mühlegger

October 10, 2022

Biopharma

How Pharma 4.0 eliminates human errors in pharmaceutical industry

Pharma 4.0 aims at improving risk management. It aims at updating the pharmaceutical industry and ensuring data integrity by incorporating advanced digital formats and enablers into the current Pharmaceutical Quality System (ICH Q10). The final goal is to minimize, if not eradicate, human error. 

michael-muehlegger

Michael Mühlegger

March 23, 2022

Cell & Gene Therapy

Cell and gene therapy: In vivo and Ex vivo in comparison

Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Ex Vivo and In Vivo are two different approaches you will learn about in this article!

michael-muehlegger

Michael Mühlegger

December 2, 2021

News

Explosive Growth Rate: Single Use Support achieves more than EUR 130 million revenue in 2021

The specialist for pharmaceutical fluid management Single Use Support continues its revenue upwards trend in 2021 with a strong and growing team of close to 150 employees.

michael-muehlegger

Michael Mühlegger

January 25, 2022

Cell & Gene Therapy

The Role of Single-Use Systems in Cell and Gene Therapies

Ensuring that cell and gene therapy products are shipped at cold temperatures with robust controls is even more important for cell & gene therapies than it is for more traditional biopharmaceutical products.

michael-muehlegger

Michael Mühlegger

July 8, 2024

News

Grand opening of Single Use Support’s second location

With the official inauguration of its second site in Hall in Tyrol, the Austrian biopharma fluid management specialist is increasing its capacities of office spaces, warehouse and production of single-use systems threefold.

michael-muehlegger

Michael Mühlegger

March 11, 2022

Newsletter subscription

Get the latest delivered directly to your inbox!

Get the latest delivered directly to your inbox! You can unsubscribe at any time, no hard feelings. Privacy policy.